Skip to main content

Table 2 Candidate lncRNAs biomarkers associated with clinically molecular subtype and prognosis of DLBCL

From: Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma

Ensembl id

Gene symbol

Chromosomal position

p-value

FDR

signal-to-noise ratio

ENSG00000226688.5

ENTPD1-AS1

Chr 10: 95,753,206-96,090,238 (−)

5.34E-10

1.78E-07

0.453

ENSG00000229558.2

SACS-AS1

Chr 13: 23,418,971-23,428,869 (+)

2.2E-07

3.94E-05

0.404

ENSG00000224660.1

SH3BP5-AS1

Chr 3: 15,254,184-15,264,493 (+)

4.93E-12

3.83E-09

0.502

ENSG00000231090.1

RP11-101C11.1

Chr 1: 55,217,861-55,234,177 (+)

3.88E-09

1.13E-06

0.421

ENSG00000224730.1

AC009892.10

Chr 19: 54,635,722-54,638,892 (−)

1.03E-07

2.36E-05

0.38

ENSG00000255443.1

RP1-68D18.4

Chr 11: 35,210,343-35,214,985 (−)

3.48E-07

5.8E-05

0.361

ENSG00000236901.4

MIR600HG

Chr 9: 123,109,494-123,115,477 (−)

9.02E-07

1.4E-04

0.359

ENSG00000279130.1

RP11-278 J6.4

Chr 5: 143,406,959-143,407,420 (+)

2.57E-06

3.737E-04

0.341

ENSG00000260303.1

RP11-203B7.2

Chr 4: 146,052,604-146,056,762 (−)

1.33E-07

2.57E-05

0.395

ENSG00000231163.4

CSMD2-AS1

Chr 1: 33,868,953-33,885,458 (+)

2.76E-10

1.29E-07

0.493

ENSG00000245864.2

CTC-467 M3.1

Chr 5: 88,676,218-88,722,831 (+)

1.12E-07

2.36E-05

0.379

ENSG00000223479.3

RP4-788P17.1

Chr 1: 73,635,216-73,715,214 (+)

2.91E-12

3.39E-09

0.514

ENSG00000259976.1

RP11-553 L6.5

Chr 3: 114,314,501-114,316,179 (−)

6.09E-08

1.58E-05

0.386

ENSG00000245694.7

CRNDE

Chr 16: 54,918,863-54,929,189 (−)

3.49E-06

4.71E-04

0.328

ENSG00000259354.4

RP11-519G16.3

Chr 15: 45,448,427-45,513,767 (+)

3.7E-10

1.44E-07

0.494

ENSG00000254418.1

RP11-21 L19.1

Chr 11: 14,262,846-14,273,691 (−)

2.96E-11

1.73E-08

0.507

ENSG00000240666.2

MME-AS1

Chr 3: 155,158,370-155,183,285 (−)

4.33E-15

1.01E-11

0.666